Furthermore, it must be outlined that high BCR–ABL/GUSIS expression is probably indicative of higher amounts of BCR::ABL1 transcripts within each leukemic cell, that is, a well-established sign of disease progression in CML [10,14]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.